[{"address1": "3710 \u2013 33rd Street NW", "city": "Calgary", "state": "AB", "zip": "T2L 2M1", "country": "Canada", "phone": "403 455 7727", "website": "https://www.xortx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "XORTX Therapeutics Inc., a late-stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat gout and progressive kidney disease. Its drug development programs include XRx-026, which is in the third phase for the treatment of gout; XRx-008, which is in the second phase to treat autosomal dominant polycystic kidney disease; XRx-101, which is in the second phase to treat acute kidney injury associated with respiratory virus infection; and XRX-225, which is in the preclinical stage for the treatment of type 2 diabetic nephropathy. It has a license agreement with the University of Florida Research Foundation, Inc. for the use of uric acid lowering agent to treat insulin resistance. The company is based in Calgary, Canada.", "companyOfficers": [{"maxAge": 1, "name": "Dr. Allen Warren Davidoff Ph.D.", "age": 65, "title": "Founder, CEO, President & Director", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 391655, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Michael Scott Bumby D.V.M., M.B.A.", "age": 61, "title": "Chief Financial Officer", "yearBorn": 1964, "fiscalYear": 2024, "totalPay": 6515, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stephen  Haworth M.D., MRCP", "age": 75, "title": "Chief Medical Officer", "yearBorn": 1950, "fiscalYear": 2024, "totalPay": 110445, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Stacy  Evans M.B.A., M.D.", "age": 51, "title": "Chief Business Officer", "yearBorn": 1974, "fiscalYear": 2024, "totalPay": 157500, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Nick  Rigopoulos", "title": "Director of Communications", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Sans M.B.A., Ph.D.", "age": 55, "title": "Director of Corporate Development", "yearBorn": 1970, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  MacDonald Ph.D.", "age": 62, "title": "Consultant of Clinical Operations", "yearBorn": 1963, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Charlotte  May", "title": "Corporate Secretary", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.5775, "open": 0.5775, "dayLow": 0.5701, "dayHigh": 0.585, "regularMarketPreviousClose": 0.5775, "regularMarketOpen": 0.5775, "regularMarketDayLow": 0.5701, "regularMarketDayHigh": 0.585, "payoutRatio": 0.0, "beta": -0.12, "forwardPE": -1.6495379, "volume": 15848, "regularMarketVolume": 15848, "averageVolume": 190670, "averageVolume10days": 30820, "averageDailyVolume10Day": 30820, "bid": 0.5807, "ask": 0.6661, "bidSize": 1, "askSize": 1, "marketCap": 3985173, "fiftyTwoWeekLow": 0.51, "fiftyTwoWeekHigh": 1.41, "allTimeHigh": 495.72, "allTimeLow": 0.51, "fiftyDayAverage": 0.58938, "twoHundredDayAverage": 0.80085, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 2850352, "profitMargins": 0.0, "floatShares": 6250610, "sharesOutstanding": 6962218, "sharesShort": 58074, "sharesShortPriorMonth": 104494, "sharesShortPreviousMonthDate": 1764288000, "dateShortInterest": 1767139200, "sharesPercentSharesOut": 0.0083, "heldPercentInsiders": 0.10135, "heldPercentInstitutions": 0.04008, "shortRatio": 1.28, "shortPercentOfFloat": 0.0085, "impliedSharesOutstanding": 6962218, "bookValue": 0.379, "priceToBook": 1.5102901, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -1943307, "trailingEps": -0.4, "forwardEps": -0.34700626, "lastSplitFactor": "1:9", "lastSplitDate": 1699920000, "enterpriseToEbitda": -1.167, "52WeekChange": -0.41928935, "SandP52WeekChange": 0.14725316, "quoteType": "EQUITY", "currentPrice": 0.5724, "targetHighPrice": 13.841179, "targetLowPrice": 13.841179, "targetMeanPrice": 13.841179, "targetMedianPrice": 13.841179, "recommendationKey": "none", "numberOfAnalystOpinions": 1, "totalCash": 1193915, "totalCashPerShare": 0.171, "ebitda": -2443400, "totalDebt": 59094, "quickRatio": 1.452, "currentRatio": 1.621, "debtToEquity": 2.994, "returnOnAssets": -0.45321998, "returnOnEquity": -0.94628, "freeCashflow": -2335485, "operatingCashflow": -2953274, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "XRTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "corporateActions": [], "shortName": "XORTX Therapeutics Inc.", "longName": "XORTX Therapeutics Inc.", "regularMarketChangePercent": -0.883119, "regularMarketPrice": 0.5724, "marketState": "CLOSED", "priceEpsCurrentYear": -0.43794948, "fiftyDayAverageChange": -0.016980052, "fiftyDayAverageChangePercent": -0.028810022, "twoHundredDayAverageChange": -0.22845, "twoHundredDayAverageChangePercent": -0.28525943, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-13", "cryptoTradeable": false, "postMarketTime": 1768599250, "regularMarketTime": 1768597201, "exchange": "NCM", "messageBoardId": "finmb_259860883", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1632403800000, "postMarketChangePercent": 0.0, "postMarketPrice": 0.5724, "postMarketChange": 0.0, "regularMarketChange": -0.00510001, "regularMarketDayRange": "0.5701 - 0.585", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 190670, "fiftyTwoWeekLowChange": 0.062399983, "fiftyTwoWeekLowChangePercent": 0.12235291, "fiftyTwoWeekRange": "0.51 - 1.41", "fiftyTwoWeekHighChange": -0.8376, "fiftyTwoWeekHighChangePercent": -0.59404254, "fiftyTwoWeekChangePercent": -41.928936, "earningsTimestamp": 1763213400, "earningsTimestampStart": 1763213400, "earningsTimestampEnd": 1763213400, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -0.4, "epsForward": -0.34700626, "epsCurrentYear": -1.307, "displayName": "XORTX Therapeutics", "trailingPegRatio": null, "__fetch_time": "2026-01-17"}]